Prelude Capital Management’s iKang Healthcare Group, Inc. KANG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-58,361
| Closed | -$1.19M | – | 2411 |
|
|
2018
Q4 | $1.19M | Buy |
+58,361
| New | +$1.04M | 0.08% | 282 |
|
|
2018
Q3 | – | Sell |
-3,156
| Closed | -$65K | – | 2209 |
|
|
2018
Q2 | $65K | Buy |
3,156
+500
| +19% | +$10.1K | ﹤0.01% | 1062 |
|
|
2018
Q1 | $53K | Buy |
+2,656
| New | +$44.7K | ﹤0.01% | 1055 |
|
|
2017
Q4 | – | Sell |
-19,500
| Closed | -$263K | – | 1911 |
|
|
2017
Q3 | $263K | Buy |
19,500
+10,000
| +105% | +$134K | 0.02% | 560 |
|
|
2017
Q2 | $117K | Hold |
9,500
| – | – | 0.01% | 736 |
|
|
2017
Q1 | $139K | Buy |
9,500
+3,800
| +67% | +$62.5K | 0.01% | 682 |
|
|
2016
Q4 | $99K | Buy |
5,700
+3,046
| +115% | +$51.6K | 0.01% | 842 |
|
|
2016
Q3 | $48K | Sell |
2,654
-218,600
| -99% | -$4.02M | 0.01% | 1055 |
|
|
2016
Q2 | $4.06M | Buy |
221,254
+216,254
| +4,325% | +$4.35M | 0.57% | 29 |
|
|
2016
Q1 | $109K | Sell |
5,000
-19,500
| -80% | -$406K | 0.02% | 736 |
|
|
2015
Q4 | $501K | Buy |
+24,500
| New | +$423K | 0.08% | 275 |
|
Prelude Capital Management's KANG Position: Q1 2019 in Review
Prelude Capital Management sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 58,361 shares — an estimated $1.19M sold.
Prelude Capital Management first reported a position in KANG in Q4 2015 and held it in 11 quarters. The position peaked at $4.06M in Q2 2016. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.
- Prelude Capital Management reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
- Prelude Capital Management sold 58,361 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $1.19M.
- Prelude Capital Management first reported a position in iKang Healthcare Group, Inc. in Q4 2015 and held it in 11 quarters.
- Prelude Capital Management's iKang Healthcare Group, Inc. position peaked at $4.06M in Q2 2016.
- 0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.
Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.